Melanoma incidence rates among whites in the U.S. military

Cancer Epidemiology Biomarkers and Prevention

Volumn 20, Issue 2, 2011, Pages 318-323

  Zhou, Jing ^a   Enewold, Lindsey ^a   Zahm, Shelia H ^b   Devesa, Susan S ^b   Anderson, William F ^b   Potter, John F ^a,c   McGlynn, Katherine A ^b   Zhu, Kangmin ^a,c  

^a WALTER REED ARMY MEDICAL CENTER   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AIR FORCE; ARMY; ARTICLE; CANCER CENTER; CANCER INCIDENCE; CASE REPORT; CONTROLLED STUDY; FEMALE; GROUPS BY AGE; HUMAN; MALE; MELANOMA; MILITARY SERVICE; NATIONAL HEALTH ORGANIZATION; POPULATION; PRIORITY JOURNAL; RISK FACTOR; SEX DIFFERENCE; SOLDIER;

ADULT; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; MALE; MELANOMA; MIDDLE AGED; MILITARY PERSONNEL; RISK FACTORS; SEER PROGRAM; SKIN NEOPLASMS; SUNLIGHT; UNITED STATES; YOUNG ADULT;

EID: 79951620803     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-10-0869     Document Type: Article

References (44)

1. American Cancer Society. Cancer Facts and Figures 2010. Atlanta, GA: American Cancer Society; 2010.
2. Leiter U, Garbe C. Epidemiology of melanoma and nonmelanoma skin cancer-the role of sunlight. Adv Exp Med Biol 2008;624:89-103.
3. Situm M, Buljan M, Bulic SO, Simic D. The mechanisms of UV radiation in the development of malignant melanoma. Coll Antropol 2007;31 Suppl 1:13-6.
4. Markovic SN, Erickson LA, Rao RD, Weening RH, Pockaj BA, Bardia A, et al. Malignant melanoma in the 21st century, part 1: epidemiology, risk factors, screening, prevention, and diagnosis. Mayo Clin Proc 2007;82:364-80. (Pubitemid 46348938)
5. MacKie RM, Hauschild A, Eggermont AM. Epidemiology of invasive cutaneous melanoma. Ann Oncol 2009;20 Suppl 6: vi1-7.
6. Torrens R, Swan BA. Promoting prevention and early recognition of malignant melanoma. Dermatol Nurs 2009;21:115-22; quiz 123.
7. Tucker MA. Melanoma epidemiology. Hematol Oncol Clin North Am 2009;23:383-95, vii.
8. Loomis D, Browning SR, Schenck AP, Gregory E, Savitz DA. Cancer mortality among electric utility workers exposed to polychlorinated biphenyls. Occup Environ Med 1997;54:720-8. (Pubitemid 27414495)
9. Fortes C, Mastroeni S, Melchi F, Pilla MA, Alotto M, Antonelli G, et al. The association between residential pesticide use and cutaneous melanoma. Eur J Cancer 2007;43:1066-75. (Pubitemid 46483032)
10. Rager EL, Bridgeford EP, Ollila DW. Cutaneous melanoma: update on prevention, screening, diagnosis, and treatment. Am Fam Physician 2005;72:269-76. (Pubitemid 41022697)
11. Edwards BK, Ward E, Kohler BA, Eheman C, Zauber AG, Anderson RN, et al. Annual report to the nation on the status of cancer, 1975-2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates. Cancer 2010;116:544-73.
12. Ortiz CA, Goodwin JS, Freeman JL. The effect of socioeconomic factors on incidence, stage at diagnosis and survival of cutaneous melanoma. Med Sci Monit 2005;11:RA163-72.
13. Kirkpatrick CS, Lee JA, White E. Melanoma risk by age and socioeconomic status. Int J Cancer 1990;46:1-4. (Pubitemid 20225777)
14. Garland FC, White MR, Garland CF, Shaw E, Gorham ED. Occupational sunlight exposure and melanoma in the U.S. Navy. Arch Environ Health 1990;45:261-7.
15. Still KR, Arfsten DP, Jederberg WW, Kane LV, Larcom BJ. Estimation of the health risks associated with polychlorinated biphenyl (PCB) concentrations found onboard older U.S. Navy vessels. Appl Occup Environ Hyg 2003;18:737-58. (Pubitemid 37205728)
16. Brown M. Toxicological assessments of Gulf War veterans. Philos Trans R Soc Lond B Biol Sci 2006;361:649-79. (Pubitemid 44858935)
17. Yamane GK. Cancer incidence in the U.S. Air Force: 1989-2002. Aviat Space Environ Med 2006;77:789-94.
18. World Health Organization. International Classification of Diseases for Oncology. Geneva: World Health Organization; 1976.
19. Percy C, Van Holten V, Muir C. International Classification of Diseases for Oncology . 2nd ed. Geneva: World Health Organization; 1990.
20. Fritz AP, Jack A, Shanmugaratnam K, Sobin L, Parkin DM, Whelan S, et al. International Classification of Disease for Oncology. 3rd ed. Geneva: World Health Organization; 2000.
21. NAACCR. ATL site pairs table. [cited 2010Aug 13]. Available from: http://www.naaccr.org/StandardsandRegistryOperations/ATLGDocs.aspx
22. National Cancer Institute. Multiple and Histology Coding Rules: NCI SEER Program, 2007. Bethesda, MD: National Cancer Institute; 2007.
23. Minnesota Cancer Surveillance System. MN-PATRL: Technical Specifications for Automated Record Consolidation. St. Paul, MN: Minnesota Department of Health; 1997-2003.
24. Surveillance Epidemiology and End Results (SEER) program. [cited 2010 Aug 13]. Available from: http://www.seer.cancer.gov.
25. Zhu K, Devesa SS, Wu H, Zahm SH, Jatoi I, Anderson WF, et al. Cancer incidence in the U.S. Military population: comparison with rates from the SEER program. Cancer Epidemiol Biomarkers Prev 2009;18:1740-5.
26. Welch ML, Anderson LL, Grabski WJ. Evaluation and management of nonmelanoma skin cancer. The military perspective. Dermatol Clin 1999;17:19-28, vii.
27. U.S. Army Center for Health Promotion and Preventive Medicine. Medical Fact sheet on sunlight and skin cancer risks. [cited 2010 Oct 19]. Available from: http://phc.amedd.army.mil/PHC%20Resource%20Library/25-019- 1205FSSunlightandSkinCancerRisks.pdf
28. Murphy MK. Skin cancer preventable, curable. [cited 2010 Oct 19]. Available from: http://www.armymedicine.army.mil/news/mercury/09-07/skincancer. cfm.
29. U.S. Air Force. USAF-public health information and resources. [cited 2010 Aug 13]. Available from: http://www.phsource.us/.
30. The Navy Marine Corps Public Health Center. Health promotion and wellness program. [cited 2010 Aug 13]. Available from: http://www-nehc.med.navy.mil/ About/health-info.aspx.
31. Whiteman DC, Watt P, Purdie DM, Hughes MC, Hayward NK, Green AC. Melanocytic nevi, solar keratoses, and divergent pathways to cutaneous melanoma. J Natl Cancer Inst 2003;95:806-12. (Pubitemid 36798427)
32. Roberts DJ, Hornung CA, Polk HC Jr. Another duel in the sun: weighing the balances between sun protection, tanning beds, and malignant melanoma. Clin Pediatr (Phila) 2009;48:614-22.
33. Hall HI, Miller DR, Rogers JD, Bewerse B. Update on the incidence and mortality from melanoma in the United States. J Am Acad Dermatol 1999;40:35-42. (Pubitemid 29051022)
34. Buja A, Lange JH, Perissinotto E, Rausa G, Grigoletto F, Canova C, et al. Cancer incidence among male military and civil pilots and flight attendants: an analysis on published data. Toxicol Ind Health 2005;21:273-82. (Pubitemid 43088281)
35. Reichrath J, Nurnberg B. Cutaneous vitamin D synthesis versus skin cancer development: The Janus faces of solar UV-radiation. Dermatoendocrinology 2009;1:253-61.
36. Egan KM. Vitamin D and melanoma. Ann Epidemiol 2009;19:455-61.
37. Gandini S, Raimondi S, Gnagnarella P, Dore JF, Maisonneuve P, Testori A. Vitamin D and skin cancer: a meta-analysis. Eur J Cancer 2009;45:634-41.
38. Asgari MM, Maruti SS, Kushi LH, White E. A cohort study of vitamin D intake and melanoma risk. J Invest Dermatol 2009;129:1675-80.
39. Weinstock MA, Stampfer MJ, Lew RA, Willett WC, Sober AJ. Case-control study of melanoma and dietary vitamin D: implications for advocacy of sun protection and sunscreen use. J Invest Dermatol 1992;98:809-11.
40. Woo DK, Eide MJ. Tanning beds, skin cancer, and vitamin D: An examination of the scientific evidence and public health implications. Dermatol Ther 2010;23:61-71.
41. Grant WB. How strong is the evidence that solar ultraviolet B and vitamin D reduce the risk of cancer? An examination using Hill's criteria for causality. Dermatoendocrinology 2009;1:17-24.
42. Kostner K, Denzer N, Muller CS, Klein R, Tilgen W, Reichrath J. The relevance of vitamin D receptor (VDR) gene polymorphisms for cancer: a review of the literature. Anticancer Res 2009;29:3511-36.
43. Gapska P, Scott RJ, Serrano-Fernandez P, Mirecka A, Rassoud I, Górski B, et al. Vitamin D receptor variants and the malignant melanoma risk: a population-based study. Cancer Epidemiol 2009; 33:103-7.
44. Sertznig P, Seifert M, Tilgen W, Reichrath J. Peroxisome proliferator-activated receptor (PPAR) and vitamin D receptor (VDR) signaling pathways in melanoma cells: promising new therapeutic targets? J Steroid Biochem Mol Biol 2010;121:383-6.